Showing results (31-40 of 91) with videos related to

Sort By:
Pageof 10
Journal of Immunology (Baltimore, Md. : 1950)|August 24, 2002
Inhibition of NF-kappa B activity by a membrane-transducing mutant of I kappa B alphaPanagiotis S Kabouridis, Maemunah Hasan, Justine Newson, et al.
Fundamental & Clinical Pharmacology|June 30, 2010
Inhibition of the diclofenac-induced cyclooxygenase-2 activity by paracetamol in cultured macrophages is not related to the intracellular lipid hydroperoxide toneSamir S Ayoub, Amrish Joshi, Mary Chol, et al.
Blood|September 14, 2011
Sex differences in resident immune cell phenotype underlie more efficient acute inflammatory responses in female miceRamona S Scotland, Melanie J Stables, Shimona Madalli, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 9, 2004
A novel role for phospholipase A2 isoforms in the checkpoint control of acute inflammationDerek W Gilroy, Justine Newson, Prescilla Sawmynaden, et al.
Nature Reviews. Immunology|December 1, 2012
The resolution of inflammationChristopher D Buckley, Derek W Gilroy, Charles N Serhan, et al.
Immunological Reviews|February 13, 2014
Inflammatory triggers of acute rejection of organ allograftsDaniel N Mori, Daniel Kreisel, James N Fullerton, et al.
BJGP Open|September 22, 2022
Home-built environment interventions and inflammation biomarkers: a systematic review and meta-analysis protocolEva Hernandez-Garcia, Evangelia Chrysikou, Larissa Nekhlyudov, et al.
The Journal of Experimental Medicine|July 9, 2004
15-epi-lipoxin A4-mediated induction of nitric oxide explains how aspirin inhibits acute inflammationMark J Paul-Clark, Thong Van Cao, Niloufar Moradi-Bidhendi, et al.
British Journal of Pharmacology|January 30, 2002
Different glucocorticoids vary in their genomic and non-genomic mechanism of action in A549 cellsJamie D Croxtall, Peter Th W van Hal, Qam Choudhury, et al.
Arthritis and Rheumatism|August 31, 2004
Reduced infiltration and increased apoptosis of leukocytes at sites of inflammation by systemic administration of a membrane-permeable IkappaBalpha repressorNathan M Blackwell, Phupinder Sembi, Justine S Newson, et al.
Pageof 10